Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    Common name

    Budesonide Pressurised Inhalation Solution

    Product name Budiair®
    Common name

    Budesonide Pressurised Inhalation Solution

    Product manufacturer

    Chiesi Farmaceutici S.p.A. Italy

    Product approval

    Imported Drug Registration Certificate H20120320

    Indication

    Budiair is indicated for maintenance treatment and Prophylaxis of adult and pediatric asthma patients of 6 years of age and older. It is also indicated for asthma patients who need to take corticosteroid orally. Many of such patients are able to reduce or stop oral use of corticosteroid with time passing.Budiair is not indicated for relieving acute Bronchospasm.

    Specification

     200μg/press (200 presses each bottle)

    Dosage

    The dosage of this product should be adjusted according to patients' severity of asthma and treatment stage. 

     

    When a patient switches from other inhalation preparations to this product, an individualized dosing regimen should be adopted, taking into account the previous dosing condition, dosage and method. 

     

    For adults and children aged over 12 years: When severe asthma patients start to use inhalation glucocorticoid or reduce or stop taking oral glucocorticoid, the recommended dose is 2-4 times a day, 1 press (200 micrograms) each time.  In case of severe asthma attack, the maximum daily dose can be increased to 1600 micrograms.  The maintenance dose varies with each individual, and should be the minimum dose that can control asthma symptoms: usually once a day, one press (200 micrograms) each time. 

     

    For children aged 6 to 12: usually once a day, one press (200 micrograms) each time.  If necessary, the dose can be increased to 400 micrograms a day.  The age range within which this product is allowed depends on whether the patient can use this product correctly.  The dose should be reduced to the lowest maintenance dose that can effectively control asthma. 


    3rd Floor, Weijian Health Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.